CMS advised Bruker while Kellerhals Carrard advised Chemspeed Technologies AG on this transaction. Bruker Corporation, a Nasdaq-listed company specialized in high-value analytical and diagnostic solutions at...
Bruker Corporation’s Acquisition of Chemspeed Technologies AG
Orell Füssli’s Acquisition of Majority Stake in hep Verlag
Kellerhals Carrard acted as legal advisor to the buyer. Orell Füssli Group acquired a majority stake in hep Verlag and becomes the largest private Swiss publisher of...
Ameliora Wealth Management’s Acquisition of UBP’s Swiss Offshore Business
Kellerhals Carrard advised Ameliora Wealth Management. Ameliora Wealth Management announced the acquisition of the Swiss offshore business with American private clients of UBP Investment Advisors. The...
Kontivia AG-Led Entrepreneurs Group’s Acquisition of Katadyn Group
Advestra advised the sellers. Kellerhals Carrard advised the investors and Kontivia AG on this transaction. Adrian Schmassmann, CEO and long-time majority shareholder of Katadyn Group, together...
MoonLake Immunotherapeutics AG’s Business Combination With Helix Acquisition Corp.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
Stille AB’s Acquisition of S & T AG
Kellerhals Carrard acted as legal advisor to STILLE in this transaction. Stille AB, a medical device company whose shares are listed on the Nasdaq First North...
MoonLake Immunotherapeutics AG’s Series A Financing Round
Kellerhals Carrard acted as lead legal advisor to MoonLake Immunotherapeutics AG on this transaction. Walder Wyss has advised Merck KGaA on the deal. MoonLake Immunotherapeutics AG,...